SAMCYPRONE
Dead / Cancelled — Cancelled — Section 8 (as of 07 Mar 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86476105
- Registration number
- 5546187
- Mark type
- Stylized text
- Filed
- 10 Dec 2014
- Published for opposition
- 19 May 2015
- Registered
- 21 Aug 2018
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Dermatological pharmaceutical products; Pharmaceutical preparations for treating alopecia; Pharmaceutical preparations for treating warts
Owner
- PHIO PHARMACEUTICALS CORP., MARLBOROUGH, MA, US
- RXi Pharmaceuticals Corporation, Marlborough, MA, US
- RXi Pharmaceuticals Corporation, Marlborough, MA, US
- RXi Pharmaceuticals Corporation, Marlborough, MA, US
Prosecution history
- 07 Mar 2025 — CANCELLED SEC. 8 (6-YR)
- 21 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Nov 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2018 — USE AMENDMENT FILED
- 03 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 03 Jul 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2018 — SOU EXTENSION 5 GRANTED
- 11 Jan 2018 — SOU EXTENSION 5 FILED
- 11 Jan 2018 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED